BDBM109317 US8609666, 37

SMILES: CN(CCO)c1cc(nc2c(nc(nc12)N1CCOCC1)-c1cccc(F)c1O)C(O)=O

InChI Key: InChIKey=CDAAJKVEGIIOSW-UHFFFAOYSA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 109317   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens (Human))	BDBM109317 (US8609666, 37) Show SMILES CN(CCO)c1cc(nc2c(nc(nc12)N1CCOCC1)-c1cccc(F)c1O)C(O)=O Show InChI InChI=1S/C21H22FN5O5/c1-26(5-8-28)15-11-14(20(30)31)23-18-16(12-3-2-4-13(22)19(12)29)24-21(25-17(15)18)27-6-9-32-10-7-27/h2-4,11,28-29H,5-10H2,1H3,(H,30,31)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Merck Serono SA US Patent					Assay Description The efficacy of compounds of the invention in inhibiting the PI3K induced-lipid phosphorylation may be tested in the following binding assay. The ass...				US Patent US8609666 (2013) BindingDB Entry DOI: 10.7270/Q26M35G5
					More data for this Ligand-Target Pair